Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

23401 - 23410 of 58327 results found

mRNA lipid nanoparticles induce immune tolerance to treat human diseases

Date
Tuesday, September 19, 2023 - 4:00 AM
Description
Rapid developments in the coronavirus disease 2019 (COVID-19) mRNA vaccine showcased the power of lipid nanoparticle (LNP) delivery systems in fighting infectious diseases. In addition, mRNA therapeutics are also in development for cancer

Early antibody treatment, inflammation, and risk of post-COVID conditions

Date
Tuesday, September 19, 2023 - 4:00 AM
Description
Post-COVID conditions (PCCs) are common and have significant morbidity. Risk factors for PCC include advancing age, female sex, obesity, and diabetes mellitus. Little is known about treatment, inflammation, and PCC. Among 882 individuals with

RNA nanomedicine in liver diseases

Date
Tuesday, September 19, 2023 - 4:00 AM
Description
The remarkable impact of RNA nanomedicine during the COVID-19 pandemic has demonstrated the expansive therapeutic potential of this field in diverse disease contexts. In recent years, RNA nanomedicine targeting the liver has been paradigm-shifting in